ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,581.50
-2.00 (-0.13%)
Last Updated: 10:35:04
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.13% 1,581.50 1,581.00 1,582.00 1,583.50 1,575.00 1,579.50 571,317 10:35:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.17 64.91B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,583.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £64.91 billion. Gsk has a price to earnings ratio (PE ratio) of 13.17.

Gsk Share Discussion Threads

Showing 20876 to 20899 of 33100 messages
Chat Pages: Latest  844  843  842  841  840  839  838  837  836  835  834  833  Older
DateSubjectAuthorDiscuss
14/3/2020
10:38
so what did they do after the massive spanish flu epidemic of the first world war?it ran its course until people developed immunity.

shutting every thing down is not going to get rid of it,in time it will come back..

i think today people are becoming hysterical about it..

lippy4
14/3/2020
10:06
Nor bacteria - Prevention of TB involves screening those at high risk, early detection and treatment of cases, and vaccination with the bacillus Calmette-Guérin (BCG) vaccine.
alphorn
14/3/2020
09:22
Herd immunity never worked on other Viruses, Measles, Polio, and even the Flu required Vaccines!
gbh2
14/3/2020
08:57
Think that part of the strategy is to enable the NHS to cope - avoid sudden large increase in patients.
poikka
13/3/2020
20:32
Essential - "I suppose when you are in good health you can use terms like herd instinct with impunity, some of us would prefer not to catch this."

"Herd IMMUNITY", Essential, and that includes vaccination. Relax, bro'.

poikka
13/3/2020
19:17
GSK is not developing a vaccine but they are providing a proprietary adjuvant for a vs vaccine
tradermichael
13/3/2020
13:06
will they launch a vaccine
onjohn
13/3/2020
12:46
Yes, GBP 1.0 = USD 1.25
tradermichael
13/3/2020
12:38
Weak sterling helps GSK and other dollar earners.
montyhedge
13/3/2020
11:36
monty,
Not necessarily a good thing as there is not much spare capacity for vaccines production at GSK. Look at the delays to global marketing of Shingrix - new plant (Belgium) won't be running till 2024. Last thing GSK wants is governments to commandeer facilities that GSK needs for lucrative production.

tradermichael
13/3/2020
11:23
I suppose when you are in good health you can use terms like herd instinct with impunity, some of us would prefer not to catch this.
essentialinvestor
13/3/2020
11:18
You would think so, Monty.

"Coronavirus is likely to return “year on year” and millions of Britons will need to become infected to control the impact of the disease, the government’s chief scientific advisor has said. Sir Patrick Vallance told Sky News around 60% of the UK population would need to contract the deadly COVID-19 in order for society to develop “herd immunity” from future outbreaks."

poikka
13/3/2020
10:59
If vaccines found and they reckon not far off, surely GSK vaccine facilities will help produce it.
montyhedge
12/3/2020
15:02
TM has balls of steel :)
crossing_the_rubicon
12/3/2020
14:36
You can sleep at night holding GSK. Just holding GSK, less sure about,
but Michael knows what he's doing I'm sure.

essentialinvestor
12/3/2020
14:34
I only hold 11 companies, TM holds 1 :-)
sicker
12/3/2020
14:00
That is just 11 cuts.........so far!
abdullla
12/3/2020
13:57
I think we're all saying that tbh!

spud

spud
12/3/2020
13:51
TM is saying 'ouch'
I'm saying 'ouch' 'ouch' 'ouch' 'ouch' 'ouch' 'ouch' 'ouch' 'ouch' 'ouch' 'ouch' 'ouch'
:-)

sicker
12/3/2020
13:11
It is like dying with thousand cuts,mercy!
abdullla
12/3/2020
11:41
Yes, very true, Michael. It's just knowing the where's and when's. My diversity has backfired now. I was all in with GSK at the start, watched it go from £15.50 or so to £12.80 back in early 2017, that was what caused my diversity to start with! You gotta smile.
daveboy1
12/3/2020
10:38
Very true, but I trust that GSK has a diverse range of new potential drugs and existing products to carry that, and that any business failures do not coincide with a market crash.
tradermichael
12/3/2020
10:33
TM - possibly. The big additional risk in a single investment in Big Pharma is a major drug candidate failure or even worse a major problem with an existing approved drug. I.e. company specific rather than market driven.
alphorn
12/3/2020
10:30
This is the thing with 'all in one basket' versus a 'diverse portfolio', at times like this the market is driven by fear and panic. Most, if not all stocks are affected by massive falls, no matter what sector.

Holding a single company (like GSK) is sometimes more safe for the recovery if you have a defensive stock. In a diverse portfolio, a proportion of the shares will recover in line with the market (or better) while others can get left behind. That takes some clever management to get back to performance.

tradermichael
Chat Pages: Latest  844  843  842  841  840  839  838  837  836  835  834  833  Older

Your Recent History

Delayed Upgrade Clock